| For: | Lymperopoulos A, Aukszi B. Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy. World J Cardiol 2017; 9(3): 200-206 [PMID: 28400916 DOI: 10.4330/wjc.v9.i3.200] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v9/i3/200.htm |
| Number | Citing Articles |
| 1 |
Ahmed Rakib, Taslima Akter Eva, Saad Ahmed Sami, Saikat Mitra, Iqbal Hossain Nafiz, Ayan Das, Abu Montakim Tareq, Firzan Nainu, Kuldeep Dhama, Talha Bin Emran, Jesus Simal-Gandara. Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review. Pharmaceutics 2021; 13(6) doi: 10.3390/pharmaceutics13060838
|
| 2 |
Jordana I. Borges, Krysten E. Ferraino, Natalie Cora, Deepika Nagliya, Malka S. Suster, Alexandra M. Carbone, Anastasios Lymperopoulos. Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair. Journal of Cardiovascular Pharmacology 2022; 80(3) doi: 10.1097/FJC.0000000000001213
|
| 3 |
Kathryn L. Bradford, Meghan Pearl, Donald B. Kohn, Patricia Weng, Ora Yadin, La Vette Bowles, Satiro N. De Oliveira, Theodore B. Moore. AT1R Activating Autoantibodies in Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2020; 26(11) doi: 10.1016/j.bbmt.2020.07.029
|
| 4 |
Sara Erraez, Manuel López-Mesa, Pablo Gómez-Fernández. Bloqueantes del receptor mineralcorticoide en la enfermedad renal crónica. Nefrología 2021; 41(3) doi: 10.1016/j.nefro.2020.10.001
|
| 5 |
Anastasios Lymperopoulos, Jordana I. Borges, Alexandra M. Carbone, Natalie Cora, Anastasiya Sizova. Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling. Pharmacological Research 2021; 174 doi: 10.1016/j.phrs.2021.105943
|
| 6 |
Celina M Pollard, Malka S Suster, Natalie Cora, Alexandra M Carbone, Anastasios Lymperopoulos. GRK5 is an essential co-repressor of the cardiac mineralocorticoid receptor and is selectively induced by finerenone. World Journal of Cardiology 2022; 14(4): 220-230 doi: 10.4330/wjc.v14.i4.220
|
| 7 |
Xiaohai Zhang, Nancy L. Reinsmoen. Angiotensin II type I receptor antibodies in thoracic transplantation. Human Immunology 2019; 80(8) doi: 10.1016/j.humimm.2019.04.007
|
| 8 |
Sara Erraez, Manuel López-Mesa, Pablo Gómez-Fernández. Mineralcorticoid receptor blockers in chronic kidney disease. Nefrología (English Edition) 2021; 41(3) doi: 10.1016/j.nefroe.2021.08.001
|
| 9 |
Celina Pollard, Jennifer Ghandour, Natalie Cora, Arianna Perez, Barbara Parker, Victoria Desimine, Shelby Wertz, Janelle Pereyra, Krysten Ferraino, Jainika Patel, Anastasios Lymperopoulos. GRK2-Mediated Crosstalk Between β-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo. International Journal of Molecular Sciences 2020; 21(2) doi: 10.3390/ijms21020574
|
| 10 |
Ehab S. EL Desoky, Ayman K. M. Hassan, Safaa Y. Salem, Sabah A. Fadil, Amira F. Taha. Cardioprotective Effect of Losartan Alone or in Combination with Remote Ischemic Preconditioning on the Biochemical Changes Induced by Ischemic/Reperfusion Injury in a Mutual Prospective Study with a Clinical and Experimental Animal Arm. Heart Research - Open Journal 2017; 4(3) doi: 10.17140/hroj-4-142
|
| 11 |
Anastasios Lymperopoulos. . Progress in Molecular Biology and Translational Science 2018; 159 doi: 10.1016/bs.pmbts.2018.07.003
|
| 12 |
Richard A. Bond, Emilio Y. Lucero Garcia-Rojas, Akhil Hegde, Julia K. L. Walker. Therapeutic Potential of Targeting ß-Arrestin. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00124
|
| 13 |
Hideaki Kanki, Tsutomu Sasaki, Shigenobu Matsumura, Satoru Yokawa, Toshiro Yukami, Munehisa Shimamura, Manabu Sakaguchi, Tadahide Furuno, Takahiro Suzuki, Hideki Mochizuki. β-arrestin-2 in PAR-1-biased signaling has a crucial role in endothelial function via PDGF-β in stroke. Cell Death & Disease 2019; 10(2) doi: 10.1038/s41419-019-1375-x
|
| 14 |
Anastasios Lymperopoulos, Jordana I. Borges, Malka S. Suster. Adrenal Gland. Vitamins and Hormones 2024; 124 doi: 10.1016/bs.vh.2023.05.001
|
| 15 |
Barbara M. Parker, Shelby L. Wertz, Celina M. Pollard, Victoria L. Desimine, Jennifer Maning, Katie A. McCrink, Anastasios Lymperopoulos. Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease. International Journal of Molecular Sciences 2018; 19(12) doi: 10.3390/ijms19123764
|
| 16 |
Natalie Cora, Jennifer Ghandour, Celina Marie Pollard, Victoria Lynn Desimine, Krysten Elaine Ferraino, Janelle Marie Pereyra, Rachel Valiente, Anastasios Lymperopoulos. Nicotine-induced adrenal beta-arrestin1 upregulation mediates tobacco-related hyperaldosteronism leading to cardiac dysfunction. World Journal of Cardiology 2020; 12(5): 192-202 doi: 10.4330/wjc.v12.i5.192
|
| 17 |
Krysten E. Ferraino, Natalie Cora, Celina M. Pollard, Anastasiya Sizova, Jennifer Maning, Anastasios Lymperopoulos. Adrenal angiotensin II type 1 receptor biased signaling: The case for “biased” inverse agonism for effective aldosterone suppression. Cellular Signalling 2021; 82 doi: 10.1016/j.cellsig.2021.109967
|
| 18 |
Anastasios Lymperopoulos, Jordana I. Borges. Arrestins. 2022; doi: 10.1016/B978-0-323-85756-7.00008-X
|
| 19 |
Anastasios Lymperopoulos, Shelby L Wertz, Celina M Pollard, Victoria L Desimine, Jennifer Maning, Katie A McCrink. Not all arrestins are created equal: Therapeutic implications of the functional diversity of the β-arrestins in the heart. World Journal of Cardiology 2019; 11(2): 47-56 doi: 10.4330/wjc.v11.i2.47
|
| 20 |
Walter Gottlieb Land. Damage-Associated Molecular Patterns in Human Diseases. 2020; doi: 10.1007/978-3-030-53868-2_2
|
| 21 |
Uma Markan, Samhitha Pasupuleti, Celina M. Pollard, Arianna Perez, Beatrix Aukszi, Anastasios Lymperopoulos. The place of ARBs in heart failure therapy: is aldosterone suppression the key?. Therapeutic Advances in Cardiovascular Disease 2019; 13 doi: 10.1177/1753944719868134
|
| 22 |
Mariona Guitart-Mampel, Pedro Urquiza, Jordana I. Borges, Anastasios Lymperopoulos, Maria E. Solesio. Impact of Aldosterone on the Failing Myocardium: Insights from Mitochondria and Adrenergic Receptors Signaling and Function. Cells 2021; 10(6) doi: 10.3390/cells10061552
|
| 23 |
Jordana I. Borges, Alexandra M. Carbone, Natalie Cora, Anastasiya Sizova, Anastasios Lymperopoulos. Pharmacogenomics in Drug Discovery and Development. Methods in Molecular Biology 2022; 2547 doi: 10.1007/978-1-0716-2573-6_12
|
| 24 |
Shelby L. Wertz, Victoria L. Desimine, Jennifer Maning, Katie A. McCrink, Anastasios Lymperopoulos. G Protein-Coupled Receptors, Part B. Methods in Cell Biology 2019; 149 doi: 10.1016/bs.mcb.2018.09.003
|
| 25 |
Maria E Solesio, Erna Mitaishvili, Anastasios Lymperopoulos. Adrenal βarrestin1 targeting for tobacco–associated cardiac dysfunction treatment: Aldosterone production as the mechanistic link. Pharmacology Research & Perspectives 2019; 7(4) doi: 10.1002/prp2.497
|
| 26 |
Abdolhamid Esmaeeli, Fatemeh Ebrahimi, Kaveh Tanha, Majid Assadi, Mohammad Seyedabadi. Low-dose angiotensin AT1 receptor β-arrestin-biased ligand, TRV027, protects against cisplatin-induced nephrotoxicity. Pharmacological Reports 2020; 72(6) doi: 10.1007/s43440-020-00172-5
|
| 27 |
András D. Tóth, Gábor Turu, László Hunyady, András Balla. Novel mechanisms of G-protein-coupled receptors functions: AT1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talk. Best Practice & Research Clinical Endocrinology & Metabolism 2018; 32(2) doi: 10.1016/j.beem.2018.02.003
|
| 28 |
G Protein-Coupled Receptors: Emerging Paradigms in Activation, Signaling and Regulation Part B. International Review of Cell and Molecular Biology 2018; 339 doi: 10.1016/bs.ircmb.2018.02.007
|
| 29 |
Neng Jiang, Yuling Zhang, Yue Tang, Hongmei Tan. Comparative efficacy and safety of different SGLT2 inhibitor-based combination strategies in HFrEF: a systematic review and network meta-analysis. Frontiers in Endocrinology 2026; 16 doi: 10.3389/fendo.2025.1742128
|